Abstract: The invention relates to an antimicrobial coating composition formed by admixing choline bitartrate or choline chloride, an aminopropyltrialkoxysilane and water. This coating composition is preferably sprayed onto a surface and allowed to dry. Preferably the surface is a stainless steel surface. The coating reduces the amount of E. Coli on the surface of the substrate.

Abstract: An anti-microbial coating formulation consisting essentially of triethanolamine and a silane.

Abstract: A method of coating a surface with an antimicrobial coating comprises spray-coating a mixture of 3-aminopropylsilane triol and triethanolamine on the surface. The coating is capable of reducing the number of Murine norovirus and E. Coli inoculated on the dried coating. In various examples, the method further comprises the step of spray-coating a mixture of peroxotitanium acid and peroxo-modified anatase sol on the surface. The compositions may be electrostatically sprayed on the surface, and in certain examples, a mixture of silanol and triethanolamine is spray-coated on the surface followed by an aqueous mixture of peroxotitanium acid and peroxo-modified anatase sol.

Abstract: The present disclosure provides antimicrobial coatings on a surface comprising a reactive silanol and triethanolamine. In various examples the reactive silane is 3-chloropropylsilane triol. The coating is capable of reducing the number of Murine norovirus and E. Coli inoculated on the dried coating. In various examples, the coating further comprises a mixture of peroxotitanium acid and peroxo-modified anatase sol. The compositions may be electrostatically sprayed on the surface, and in certain examples, a mixture of silanol and triethanolamine is spray-coated on the surface followed by an aqueous mixture of peroxotitanium acid and peroxo-modified anatase sol.

Abstract: A polymeric material formed by reacting aminopolyol having a structure: wherein R4 is selected from the group consisting of —H and —CH2—CH2—OH; and an organosilane, wherein said organosilane has a structure: wherein R1 is selected from the group consisting of —H, —CH3 and —CH2—CH3 and R2 is selected from the group consisting of —OH, —O—CH3, O—CH2—CH3, alkyl, alkyl with a chlorine moiety, alkyl with an amino moiety, and alkyl with a quaternary ammonium group.

Abstract: A polymeric material formed by reacting aminopolyol having a structure: wherein R4 is selected from the group consisting of —H and —CH2—CH2—OH; and an organosilane, wherein said organosilane has a structure: wherein R1 is selected from the group consisting of —H, —CH3 and —CH2—CH3 and R2 is selected from the group consisting of —OH, —O—CH3, O—CH2—CH3, alkyl, alkyl with a chlorine moiety, alkyl with an amino moiety, and alkyl with a quaternary ammonium group.

Abstract: An anti-microbial coating formulation consisting essentially of triethanolamine and a silane.

Abstract: An anti-microbial coating formulation consisting essentially of triethanolamine and a silane.

Abstract: An anti-microbial coating formulation consisting essentially of triethanolamine and a silane.

Abstract: An anti-microbial coating formulation consisting essentially of triethanolamine and a silane.

Abstract: A polymeric material formed by reacting aminopolyol having a structure: wherein R4 is selected from the group consisting of —H and —CH2—CH2—OH; and an organosilane, wherein said organosilane has a structure: wherein R1 is selected from the group consisting of —H, —CH3 and —CH2—CH3 and R2 is selected from the group consisting of —OH, —O—CH3, O—CH2—CH3, alkyl, alkyl with a chlorine moiety, alkyl with an amino moiety, and alkyl with a quaternary ammonium group.

Abstract: The present invention is directed to improved liquid antibiotic formulations. In some embodiments, the present invention is directed to a composition comprising an antibiotic in a liquid comprising triglycerides, wherein the composition has less than about 5% water (w/v).

Abstract: The present invention is directed to improved liquid antibiotic formulations. In some embodiments, the present invention is directed to a composition comprising an antibiotic in a liquid comprising triglycerides, wherein the composition has less than about 5% water (w/v).

Abstract: A cooktop apparatus, in particular an induction cooktop apparatus, includes a switching unit configured to interrupt and establish current flow from a current supply, a first switching element receiving the current flow during an operating process, a control apparatus, which controls the switching unit during the operating process such that the switching unit interrupts the current supply during a first time interval which has a duration of less than of half a period of the power supply voltage. The control apparatus causes the current supply to be connected during the operating process immediately before and immediately after the first time interval. The first switching element begins switching and ends switching during the first time interval.

Abstract: A method of treating movement disorders comprises administering to a human or animal subject in need of treatment a therapeutically effective amount of at least one compound according to the following formula: wherein R3 and R4 are each independently selected from the group consisting of lower alkyl, phenyl and lower alkyl substituted phenyl, and R1 and R2 are each independently either a hydrogen atom or a radical of the formula wherein R5 and R6 are each independently selected from the group consisting of H, lower alkyl, phenyl and lower alkyl substituted phenyl, its pharmaceutically acceptable salts, prodrugs or metabolites thereof.

Abstract: A cook top with at least two heating elements includes a power electronics arrangement connected to a domestic single phase AC supply. The power electronics arrangement includes several power supply units, which each supply heating currents to one or more heating elements, and a switch arrangement with several electromechanical relays for connecting/disconnecting the power supply units to/from the heating elements. Output poles of at least two electromechanical relays associated with different power supply units are connected in parallel, wherein the parallel connection is permanently connected to at least one of the heating elements. This arrangement reduces the number of switching processes required for alternating use of a power supply device with several heating elements, and simplifies compliance with electromagnetic compatibility standards.

Abstract: The present invention provides a topical gel pharmaceutical formulation of insecticide suitable for treating an ectoparasite in a mammal, comprising: a) about 0.1-10% by weight of an insecticide; b) at least about 75% by weight of an organic solvent selected from the group consisting of a lower alkyl alcohol, a ketone, a glycol and a mixture thereof, wherein the organic solvent contains at least about 40% by weight of the lower alkyl alcohol; and c) at least one polymer selected from the group consisting of a cellulosic polymer, acrylates, methacrylates, and polyvinyl pyrrolidone. The present topical formulations encompass a non-flammable solvent for malathion effective in killing head lice. The present gel pharmaceutical formulation preferably contains malathion and optionally contains isopropyl myristate. The present invention further provides a process of preparing as well as a method of treating ectoparasites in a mammal using the same.

Abstract: The present invention provides a topical gel pharmaceutical formulation of insecticide suitable for treating an ectoparasite in a mammal, comprising: a) about 0.1-10% by weight of an insecticide; b) at least about 75% by weight of an organic solvent selected from the group consisting of a lower alkyl alcohol, a ketone, a glycol and a mixture thereof, wherein the organic solvent contains at least about 40% by weight of the lower alkyl alcohol; and c) at least one polymer selected from the group consisting of a cellulosic polymer, acrylates, methacrylates, and polyvinyl pyrrolidone. The present topical formulations encompass a non-flammable solvent for malathion effective in killing head lice. The present gel pharmaceutical formulation preferably contains malathion and optionally contains isopropyl myristate. The present invention further provides a process of preparing as well as a method of treating ectoparasites in a mammal using the same.

Abstract: Methods of providing neuroprotection are disclosed comprising administering a non-sedative barbiturate compound in an amount sufficient to achieve neuroprotection in a mammalian subject. Preferred compounds are in the family of diphenylbarbituric acid and analogs. Preferred doses for a neuroprotective effect exceed the dosage of a corresponding sedative barbiturate without sedative side-effects such as anesthesia and death.

Abstract: The present invention is directed to improved liquid antibiotic formulations. In some embodiments, the present invention is directed to a composition comprising an antibiotic in a liquid comprising triglycerides, wherein the composition has less than about 5% water (w/v).